Showing results (171-180 of 270) with videos related to

Sort By:
Pageof 27
Stem Cells (Dayton, Ohio)|November 26, 2014
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomasGiulia Grisendi, Carlotta Spano, Naomi D'souza, et al.
BMC Cancer|March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
American Journal of Cancer Research|October 22, 2011
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the MesenkillersGiulia Grisendi, Rita Bussolari, Elena Veronesi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) studyNicola Normanno, Antonella De Luca, Riziero Esposito Abate, et al.
Frontiers in Oncology|April 21, 2025
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancerAlessandro Dal Maso, Federica Ferrarini, Giovanni Esposito, et al.
The Oncologist|November 15, 2017
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast CancerMaria Vittoria Dieci, Valentina Guarneri, Tommaso Giarratano, et al.
Translational Lung Cancer Research|February 11, 2021
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcomeAlberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti, et al.
The Oncologist|March 23, 2024
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-WorldGiulia Pasello, Martina Lorenzi, Daniela Scattolin, et al.
The Oncologist|June 2, 2019
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE StudyMaria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA TrialMaria Vittoria Dieci, Valentina Guarneri, Anna Tosi, et al.
Pageof 27